Jennifer Travers 💙

Haematologist and mother of daughters.

[Jennifer Travers 💙 @TraversJen]

@vfsglobalcare My daughter has not got anywhere in Edinburgh and is being told NO to continuing her application from yesterday and needs a new appointment. There are no appointments!!Deeply frustrating- how can we help our UK #students study abroad and improve this process?

[Jennifer Travers 💙 @TraversJen]

@VFSGlobal please can you help my daughter who is in your Edinburgh centre at the moment.
Having waited 6 weeks for an appointment yesterday, she was sent away having misunderstood the information. She has arrived back with you to complete her application, please assist her 🙏

[Jennifer Travers 💙 @TraversJen]

@VFSGlobal please can you help my daughter who is in your Edinburgh centre at the moment.
Having waited 6 weeks for an appointment yesterday, she was sent away having misunderstood the information. She has arrived back with you to complete her application, please assist her 🙏

[Rahul Banerjee, MD, FACP @RahulBanerjeeMD]

They say that, if you ask 3 myeloma experts the same question, you’ll get 5 different answers…

… finally, now, a question we can all agree on answer to: YES!

See you all in 🏴󠁧󠁢󠁳󠁣󠁴󠁿 for #IMS26 in September!

@szusmani @HiraSMian @Mohty_EBMT @UsuarezMD @EliasKarlMai @SurbhiSidanaMD

[awechalekar @awechalekar]

A new era in AL staging - AL International Staging system (AL-ISS) - great presentation by ⁦@JahanzaibKhwaja⁩ and now published in ⁦@JCO_ASCO⁩

[Matt Wilson @mattwilson2287]

https://t.co/C14tVjqPbO

[Myeloma UK @MyelomaUK]

1/2 Many people living with myeloma experience symptoms for months or even years before receiving a diagnosis.

By sharing this post, you can help raise awareness and make sure more people recognise the warning signs sooner ⚠️ #MyelomaAwarenessWeek #MyelomaWarningSigns

[Thanos Dimopoulos @thanosdimop]

Honored to present tomorrow at EHA Milan!Gold Hall at 11 am Sunday June 15 All but one patient responded!Amaizing data which will be the experimental arm of an upcoming randomized study in ND NTE MM patients

[Rakesh Popat @DrRakeshPopat]

Late breaking abstract 📢
Tec + Tal showing high response in EMD with strict central response assessments. Good to see dual antigen targeting making a difference in this high risk group. #mmsm #EHA2025

[Simon Stern @DrSStern]

@DrRakeshPopat flying the flag for the UK Myeloma community with a presentation of very impressive results with the use of trispecific antibody JNJ-5322 in the Plenary session at #EHA2025

[Rakesh Popat @DrRakeshPopat]

Kwee Yong from @uclcancer making the case we need to understand the biology of smouldering myeloma better to pick the right intervention. #EHA2025

[awechalekar @awechalekar]

@EHA plenary session - ⁦@DrRakeshPopat⁩ presenting JNJ-5322 - a trispecific antibody in relapse refractory myeloma. A new potential step change for RR MM

[Andrea Preston @AndreaDPreston1]

Reminder to @BOPACommittee, @APTUK1 and @UKONSmember …6 days to IMS abstract deadline …. A fantastic opportunity to showcase your amazing work 💥💥

[Martin Kaiser @MyMKaiser]

Looking forward to speaking on treatment of High-risk #myeloma at @EHA_Hematology conference in Milano in June - many thanks @Myeloma_Society and EHA for invite. In the meantime, hope people might enjoy our @BritSocHaem podcast on this topic:
https://t.co/wabqo5CZzP

[Simon Stern @DrSStern]

Another important contribution to the debate on limiting lenalidomide maintenance post-ASCT.
Sustained bone marrow and imaging MRD negativity for 3 years drives discontinuation of maintenance post-ASCT in myeloma https://t.co/U8I1gIe3Sq

[awechalekar @awechalekar]

A opportunity to join our research team - Haematology trainees interested in plasma cell disorders - DM if interested @UKMyelomaSoc @BritSocHaem @ASH_hematology

[Jennifer Travers 💙 @TraversJen]

@VincentRK @rajshekharucms Very helpful discussion.

[Vincent Rajkumar @VincentRK]

Solitary plasmacytoma.
One lesion, but 3 possible entities with differing prognosis in the differential diagnosis.

Outcomes and management. ⁦@MayoMyeloma⁩ ⁦@BloodAdvances⁩ ⁦@ASH_hematology⁩ https://t.co/f1ZE9EBv8R

[ESH (Haematology) @ESHaematology]

REGISTRATION IS OPEN FOR #ESHMM2026
March 26-28, 2026 / Stockholm, Sweden
8th Translational Research Conference
Multiple Myeloma
Chairs : Hartmut Goldschmidt, @MyMKaiser, @SLentzsch
To register & for more information 👉https://t.co/zITdtTOZdh
#ESHCONFERENCES #MMsm #HAEMATOLOGY

[Emma Williams @EmmaDW321]

A fantastic day at the Sanius Healthcare Professional and Patient conference today.Our session highlighted many important considerations for patients to think about when going on a trial and some pertinent issues around diversity in clinical trials @AndreaDPreston1